DelveInsight Business Research LLP

DelveInsight’s “COVID-19 Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the COVID-19 pipeline landscapes. It comprises COVID-19 pipeline drug profiles, including clinical and non-clinical stage products. It also includes the COVID-19 therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive COVID-19 pipeline products.     

Some of the key takeaways of the COVID-19 Pipeline Report:

• Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as, Amgen, Corvus Pharmaceuticals, Fulcrum Therapeutics, Synairgen Research. Revive Therapeutics, Novavax, Valneva, etc., are developing therapies for the treatment of COVID-19.

• Emerging therapies such as Otezla (Apremilast), CPI-006, Losmapimod, SNG001 (Interferon beta-1a), Bucillamine, NVX-CoV2373, VLA2001, are expected to have a significant impact on the  COVID-19 market in the coming years.

Get an overview of pipeline landscape @ COVID-19 Clinical Trials Analysis 

COVID-19 Overview

COVID-19 is an infectious disease caused by a newly discovered coronavirus, i.e., SARS-CoV-2. It spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. CoVs are enveloped, positive-stranded RNA viruses with nucleocapsids. The pathogenic mechanism which causes pneumonia seems to be complex

COVID-19 Emerging Drugs

• Otezla (Apremilast): Amgen

• CPI-006: Corvus Pharmaceuticals

• Losmapimod: Fulcrum Therapeutics

• SNG001 (Interferon beta-1a): Synairgen Research

• Bucillamine: Revive Therapeutics

• NVX-CoV2373: Novavax

• VLA2001: Valneva

For further information, refer to the detailed report @ COVID-19 Pipeline Therapeutics 

Scope of COVID-19 Pipeline Drug Insight    

• Coverage: Global 

• Major Players: Amgen, Corvus Pharmaceuticals, Fulcrum Therapeutics, Synairgen Research. Revive Therapeutics, Novavax, Valneva, and others.

• Pipeline Therapies: Otezla (Apremilast), CPI-006, Losmapimod, SNG001 (Interferon beta-1a), Bucillamine, NVX-CoV2373, VLA2001, and others.

Table of Contents

Get a customized pipeline report @ COVID-19 Drugs Pipeline Report

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/